| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MED20 MARS2 TUT4 ATAD5 POLR2E WRN DHX57 SMARCAD1 DDX18 XRN1 NAV2 N4BP1 DDX41 CNOT1 TOP2A TOP2B | 5.69e-06 | 645 | 132 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.00e-04 | 127 | 132 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYL6 ATAD5 TMEM94 WRN DHX57 UBA3 SMARCAD1 DNAH7 DDX18 NAV2 DDX41 TOP2A TOP2B | 2.19e-04 | 614 | 132 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | Y-form DNA binding | 2.58e-04 | 4 | 132 | 2 | GO:0000403 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 2.58e-04 | 4 | 132 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 4.60e-04 | 417 | 132 | 10 | GO:0140098 | |
| GeneOntologyMolecularFunction | helicase activity | 6.44e-04 | 158 | 132 | 6 | GO:0004386 | |
| Domain | - | 4.66e-05 | 2 | 128 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 4.66e-05 | 2 | 128 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 4.66e-05 | 2 | 128 | 2 | PF00204 | |
| Domain | - | 4.66e-05 | 2 | 128 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 4.66e-05 | 2 | 128 | 2 | IPR018522 | |
| Domain | Topo_IIA | 4.66e-05 | 2 | 128 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 4.66e-05 | 2 | 128 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 4.66e-05 | 2 | 128 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 4.66e-05 | 2 | 128 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 4.66e-05 | 2 | 128 | 2 | IPR013759 | |
| Domain | TOP4c | 4.66e-05 | 2 | 128 | 2 | SM00434 | |
| Domain | TOP2c | 4.66e-05 | 2 | 128 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 4.66e-05 | 2 | 128 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 4.66e-05 | 2 | 128 | 2 | IPR013506 | |
| Domain | DTHCT | 4.66e-05 | 2 | 128 | 2 | PF08070 | |
| Domain | - | 4.66e-05 | 2 | 128 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 4.66e-05 | 2 | 128 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 4.66e-05 | 2 | 128 | 2 | PF16898 | |
| Domain | Cl_channel-K | 4.66e-05 | 2 | 128 | 2 | IPR002250 | |
| Domain | Topo_IIA_A/C | 4.66e-05 | 2 | 128 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 4.66e-05 | 2 | 128 | 2 | PS00177 | |
| Domain | Arg_repress_C-like | 1.39e-04 | 3 | 128 | 2 | IPR024946 | |
| Domain | Lupus_La | 1.39e-04 | 3 | 128 | 2 | IPR002344 | |
| Domain | - | 1.39e-04 | 3 | 128 | 2 | 3.30.1360.40 | |
| Domain | Toprim | 2.77e-04 | 4 | 128 | 2 | PF01751 | |
| Domain | Toprim_domain | 2.77e-04 | 4 | 128 | 2 | IPR006171 | |
| Domain | TOPRIM | 2.77e-04 | 4 | 128 | 2 | PS50880 | |
| Domain | Rho_GTPase_act | 2.77e-04 | 4 | 128 | 2 | IPR015767 | |
| Domain | - | RAB31 ATAD5 LSG1 WRN DHX57 SMARCAD1 DNAH7 NWD2 SBNO1 DDX18 NAV2 DDX41 HYDIN ARL14 | 6.01e-04 | 746 | 128 | 14 | 3.40.50.300 |
| Domain | P-loop_NTPase | RAB31 ATAD5 LSG1 WRN DHX57 SMARCAD1 DNAH7 NWD2 SBNO1 DDX18 NAV2 MYO18B DDX41 HYDIN ARL14 | 7.03e-04 | 848 | 128 | 15 | IPR027417 |
| Domain | Helicase_C | 8.50e-04 | 107 | 128 | 5 | PF00271 | |
| Domain | HELICc | 8.50e-04 | 107 | 128 | 5 | SM00490 | |
| Domain | Helicase_C | 8.87e-04 | 108 | 128 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 9.24e-04 | 109 | 128 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.24e-04 | 109 | 128 | 5 | PS51192 | |
| Domain | DEXDc | 9.24e-04 | 109 | 128 | 5 | SM00487 | |
| Domain | LA | 9.57e-04 | 7 | 128 | 2 | SM00715 | |
| Domain | HTH_LA | 9.57e-04 | 7 | 128 | 2 | PS50961 | |
| Domain | La | 9.57e-04 | 7 | 128 | 2 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 9.57e-04 | 7 | 128 | 2 | IPR006630 | |
| Domain | Helicase_ATP-bd | 9.63e-04 | 110 | 128 | 5 | IPR014001 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.59e-03 | 73 | 128 | 4 | IPR011545 | |
| Domain | DEAD | 1.59e-03 | 73 | 128 | 4 | PF00270 | |
| Domain | Cl-channel_core | 1.63e-03 | 9 | 128 | 2 | IPR014743 | |
| Domain | - | 1.63e-03 | 9 | 128 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.63e-03 | 9 | 128 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.63e-03 | 9 | 128 | 2 | IPR001807 | |
| Domain | SH3 | 3.76e-03 | 216 | 128 | 6 | SM00326 | |
| Domain | SH3 | 3.76e-03 | 216 | 128 | 6 | PS50002 | |
| Domain | WW | 4.09e-03 | 47 | 128 | 3 | PF00397 | |
| Domain | SH3_domain | 4.11e-03 | 220 | 128 | 6 | IPR001452 | |
| Domain | WW | 4.34e-03 | 48 | 128 | 3 | SM00456 | |
| Domain | WW_DOMAIN_1 | 5.15e-03 | 51 | 128 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 5.15e-03 | 51 | 128 | 3 | PS50020 | |
| Domain | CBS | 5.25e-03 | 16 | 128 | 2 | SM00116 | |
| Domain | WW_dom | 5.44e-03 | 52 | 128 | 3 | IPR001202 | |
| Domain | HEAT_type_2 | 5.93e-03 | 17 | 128 | 2 | IPR021133 | |
| Domain | ZF_ZZ_2 | 6.64e-03 | 18 | 128 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.64e-03 | 18 | 128 | 2 | PS01357 | |
| Domain | HATPase_c | 6.64e-03 | 18 | 128 | 2 | SM00387 | |
| Domain | ZZ | 6.64e-03 | 18 | 128 | 2 | PF00569 | |
| Pubmed | RALGAPA1 ANK2 CALD1 LSG1 CKAP5 ANKRD26 TTK TFRC ESYT2 LATS1 MAGED2 ARHGAP12 NCAPD2 XRN1 LRRC7 CRYBG3 NUDC CNOT1 PALLD HCFC1 | 4.22e-12 | 708 | 134 | 20 | 39231216 | |
| Pubmed | ZC3H14 TCF20 CALD1 MYCBP2 BCOR ANKHD1 CREBBP NEK1 MRTFB LATS1 NCAPD2 XRN1 NUDC CNOT1 PALLD HCFC1 TOP2A RSBN1L | 4.75e-12 | 549 | 134 | 18 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 MYL6 ANK2 CALD1 ATAD5 LSG1 TBC1D5 CKAP5 ANKRD26 BCOR ANKHD1 NEK1 MRTFB XRN1 MASTL NUDC UTRN PALLD HCFC1 TOP2A RSBN1L TOP2B | 1.13e-11 | 934 | 134 | 22 | 33916271 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYL6 CALD1 BMP2K TBC1D5 CKAP5 ANKRD26 TTK DNAH7 PAIP1 MEN1 ESYT2 SENP1 MRTFB LATS1 ARHGAP12 XRN1 CEP295 DDX41 NUDC CNOT1 TOP2A | 1.54e-11 | 853 | 134 | 21 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 HIVEP1 TCF20 NEDD4L MYCBP2 LSG1 TBC1D5 CKAP5 ANKRD26 TTK DNAH7 NEK1 ESYT2 LATS1 XRN1 NAV2 ARHGEF4 CRYBG3 DDX41 UTRN PALLD | 1.83e-11 | 861 | 134 | 21 | 36931259 |
| Pubmed | LARP6 ANK2 CALD1 LSG1 UBR4 ANKRD26 DHX57 NEB ZEB2 ERLEC1 SH3D21 LARP7 MEN1 TFRC LATS1 MAGED2 SBNO1 ARHGAP12 NCAPD2 XRN1 NAV2 CEP295 ARHGEF4 TOP2A TOP2B ZNF292 | 4.60e-11 | 1442 | 134 | 26 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MARS2 HIVEP1 MYL6 PITRM1 LSG1 UBR4 KIAA0586 CKAP5 SMARCAD1 ANKHD1 GRSF1 LARP7 TFRC GBA3 MAGED2 SBNO1 DDX18 NCAPD2 MYO18B DDX41 NUDC CNOT1 HCFC1 TOP2A TOP2B | 2.03e-10 | 1425 | 134 | 25 | 30948266 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZC3H14 TUT4 CALD1 BMP2K MYCBP2 ATAD5 LSG1 CKAP5 ANKRD26 DHX57 ANKHD1 TTK DDX18 XRN1 CNOT1 PALLD TOP2B ZNF292 | 4.23e-10 | 724 | 134 | 18 | 36232890 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | TCF20 UBR4 POLR2E SMARCAD1 MEN1 SENP1 MRTFB SBNO1 NCAPD2 DDX41 HCFC1 RSBN1L TOP2B | 8.40e-10 | 341 | 134 | 13 | 32971831 |
| Pubmed | HIVEP1 TCF20 MYCBP2 UBR4 CKAP5 BCOR ANKHD1 ZEB2 NEK1 MRTFB XRN1 CRYBG3 UTRN CNOT1 | 9.77e-10 | 418 | 134 | 14 | 34709266 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.29e-09 | 123 | 134 | 9 | 26912792 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 TCF20 ATAD5 WRN SMARCAD1 BCOR ZEB2 MEN1 SBNO1 MASTL ELF1 DDX41 HCFC1 TOP2A TOP2B ZNF292 | 1.90e-09 | 608 | 134 | 16 | 36089195 |
| Pubmed | TUT4 MYL6 ATAD5 RBL1 LSG1 POLR2E SMARCAD1 BCOR ANKHD1 CREBBP LARP7 SENP1 CLCNKA DDX18 XRN1 CEP295 CRYBG3 TAF4B DDX41 TOP2A RSBN1L | 2.00e-09 | 1116 | 134 | 21 | 31753913 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 RELCH RAB31 COL17A1 ANK2 TMEM94 TBC1D5 ANKRD26 WLS TMEM87A TFRC ESYT2 GPR158 NAV2 VPS13B | 6.14e-09 | 569 | 134 | 15 | 30639242 |
| Pubmed | TCF20 CKAP5 ANKRD26 TTK XRN1 LRRC7 N4BP1 CRYBG3 UTRN CNOT1 VPS13B | 6.79e-09 | 263 | 134 | 11 | 34702444 | |
| Pubmed | MED20 ZC3H14 HIVEP1 MYL6 TCF20 ARHGAP15 MYCBP2 CKAP5 BCOR CREBBP ZEB2 CCDC7 ELF1 DDX41 NUDC CNOT1 HCFC1 TOP2A TOP2B ZNF292 | 9.40e-09 | 1103 | 134 | 20 | 34189442 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TCF20 MYCBP2 LSG1 UBR4 POLR2E CKAP5 DHX57 SMARCAD1 ANKHD1 CREBBP GRSF1 TFRC MAGED2 DDX18 NCAPD2 XRN1 DDX41 GMPPB UTRN PALLD TOP2A TOP2B | 1.13e-08 | 1353 | 134 | 22 | 29467282 |
| Pubmed | ANK2 CKAP5 ANKHD1 WLS TTK TMEM87A TFRC MRTFB NCAPD2 XRN1 N4BP1 NUDC UTRN | 2.24e-08 | 449 | 134 | 13 | 31732153 | |
| Pubmed | RALGAPA1 TUT4 TCF20 MYCBP2 TMEM94 LSG1 WLS PAIP1 ERLEC1 TFRC XRN1 MASTL CEP295 N4BP1 HCFC1 RSBN1L | 2.61e-08 | 733 | 134 | 16 | 34672954 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TMEM94 LSG1 UBR4 DHX57 GRIK2 MEF2C LARP7 SENP1 NWD2 GPR158 ARHGAP12 SLIT1 TOP2B | 4.32e-08 | 475 | 134 | 13 | 31040226 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | COL17A1 CALD1 CKAP5 TTK TMEM87A ESYT2 MRTFB XRN1 NAV2 LRRC7 N4BP1 NUDC UTRN HCFC1 | 4.36e-08 | 565 | 134 | 14 | 25468996 |
| Pubmed | TCF20 NEDD4L TMEM94 CKAP5 DGKB SMARCAD1 ZEB2 MAP3K4 SLIT1 LRRC7 ARHGEF4 VPS13B | 6.55e-08 | 407 | 134 | 12 | 12693553 | |
| Pubmed | ZC3H14 TUT4 HIVEP1 TBC1D5 ANKHD1 WLS TMEM87A GRSF1 ERLEC1 CCDC7 MAGED2 HYDIN VPS13B ALPK2 ARL14 | 7.17e-08 | 686 | 134 | 15 | 29987050 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | OBSCN DHX57 NEB TMEM87A MAP3K4 NCAPD2 NAV2 NUDC CNOT1 HCFC1 HYDIN RSBN1L ZNF292 | 7.29e-08 | 497 | 134 | 13 | 36774506 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CALD1 TBC1D5 BCOR CREBBP MAGED2 SBNO1 MASTL NUDC PALLD HCFC1 TOP2A TOP2B | 1.67e-07 | 444 | 134 | 12 | 34795231 |
| Pubmed | TCF20 NEDD4L ANK2 MYCBP2 LSG1 TBC1D5 UBR4 CKAP5 GRIK2 BCOR ZEB2 SENP1 PLPPR4 MAGED2 GPR158 LRRC7 CNOT1 | 1.95e-07 | 963 | 134 | 17 | 28671696 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.11e-07 | 221 | 134 | 9 | 29991511 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 17652939 | ||
| Pubmed | 2.45e-07 | 225 | 134 | 9 | 12168954 | ||
| Pubmed | ZC3H14 TCF20 MYCBP2 UBR4 CKAP5 DHX57 ANKHD1 LARP7 DDX18 NCAPD2 XRN1 UTRN CNOT1 HCFC1 | 2.54e-07 | 653 | 134 | 14 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 MYCBP2 ATAD5 POLR2E WRN CKAP5 DHX57 GRSF1 LARP7 MAGED2 DDX18 XRN1 CNOT1 TOP2A TOP2B | 2.62e-07 | 759 | 134 | 15 | 35915203 |
| Pubmed | 3.26e-07 | 169 | 134 | 8 | 31462741 | ||
| Pubmed | CALD1 LSG1 TBC1D5 CKAP5 WLS TTK TMEM87A ESYT2 MRTFB XRN1 NUDC HCFC1 VPS13B | 3.35e-07 | 568 | 134 | 13 | 37774976 | |
| Pubmed | MARS2 ZC3H14 PITRM1 BMP2K MYCBP2 LSG1 TBC1D5 WLS TTK ERLEC1 TFRC NEK1 LATS1 N4BP1 DDX41 PALLD RSBN1L | 3.64e-07 | 1007 | 134 | 17 | 34597346 | |
| Pubmed | MED20 ZC3H14 TCF20 ATAD5 UBR4 POLR2E SMARCAD1 CREBBP LARP7 TFRC SBNO1 DDX18 NCAPD2 DDX41 HCFC1 TOP2A TOP2B | 4.01e-07 | 1014 | 134 | 17 | 32416067 | |
| Pubmed | 4.52e-07 | 242 | 134 | 9 | 34011540 | ||
| Pubmed | AKAP6 KIAA0408 HIVEP1 ANK2 MYCBP2 SGCB OBSCN ANKRD26 NEB MYO18B UTRN PALLD | 5.54e-07 | 497 | 134 | 12 | 23414517 | |
| Pubmed | HIVEP1 TCF20 PITRM1 ATAD5 UBR4 BCOR ANKHD1 CREBBP ZEB2 MEF2C TFRC MAGED2 DDX18 XRN1 ELF1 N4BP1 ZNHIT1 NUDC CNOT1 HCFC1 | 6.11e-07 | 1429 | 134 | 20 | 35140242 | |
| Pubmed | 1.02e-06 | 267 | 134 | 9 | 33417871 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.04e-06 | 197 | 134 | 8 | 20811636 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RBL1 UBR4 CKAP5 SMARCAD1 ANKHD1 CREBBP ZEB2 MEF2C LARP7 MEN1 ESYT2 NCAPD2 HCFC1 TOP2A TOP2B | 1.20e-06 | 857 | 134 | 15 | 25609649 |
| Pubmed | MED20 ZC3H14 BMP2K ATAD5 LSG1 POLR2E WRN CKAP5 DHX57 BCOR ANKHD1 GRSF1 LARP7 MEN1 ESYT2 MRTFB NCAPD2 XRN1 UTRN RSBN1L | 1.25e-06 | 1497 | 134 | 20 | 31527615 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.26e-06 | 202 | 134 | 8 | 33005030 | |
| Pubmed | RALGAPA1 ZC3H14 MYL6 PITRM1 UBA3 ANKHD1 PAIP1 MYO18B NUDC UTRN PALLD TOP2A | 1.27e-06 | 538 | 134 | 12 | 28524877 | |
| Pubmed | 1.62e-06 | 209 | 134 | 8 | 36779422 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 TCF20 MYCBP2 CKAP5 SMARCAD1 BCOR ESYT2 LATS1 MAGED2 USP42 ELF1 DDX41 TOP2A TOP2B | 1.90e-06 | 774 | 134 | 14 | 15302935 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYL6 NEDD4L LSG1 UBR4 POLR2E CKAP5 SMARCAD1 ANKHD1 GRSF1 TFRC SBNO1 DDX18 NCAPD2 DDX41 NUDC PALLD HCFC1 TOP2A TOP2B | 2.21e-06 | 1415 | 134 | 19 | 28515276 |
| Pubmed | ZC3H14 MYL6 ZEB2 USP42 NCAPD2 NUDC CNOT1 HCFC1 HYDIN TOP2A TOP2B | 2.21e-06 | 469 | 134 | 11 | 27634302 | |
| Pubmed | AKAP6 LARP6 ANK2 MYCBP2 UBR4 CKAP5 UBA3 NCKAP5 SMARCAD1 CREBBP ZEB2 DGLUCY SBNO1 DDX18 ZNHIT1 UTRN RSBN1L ZNF292 | 2.33e-06 | 1285 | 134 | 18 | 35914814 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYL6 CALD1 BMP2K TMEM94 RBL1 POLR2E EFCAB14 TTK CREBBP MAP3K4 NEK1 LATS1 DDX41 UTRN PALLD | 2.49e-06 | 910 | 134 | 15 | 36736316 |
| Pubmed | HIVEP1 TCF20 NEDD4L NCKAP5 NEB CREBBP MEF2C MAP3K4 LATS1 NAV2 ARHGEF4 | 3.11e-06 | 486 | 134 | 11 | 20936779 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYL6 BMP2K UBR4 POLR2E WRN TTK GRSF1 LARP7 TFRC ESYT2 USP42 DDX18 DDX41 NUDC HCFC1 TOP2A RSBN1L TOP2B | 3.32e-06 | 1318 | 134 | 18 | 30463901 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.87e-06 | 235 | 134 | 8 | 28378594 | |
| Pubmed | 4.01e-06 | 28 | 134 | 4 | 38324473 | ||
| Pubmed | ZC3H14 MYL6 LSG1 DHX57 PAIP1 GRSF1 LARP7 MAGED2 DDX18 DDX41 TOP2A RSBN1L TOP2B | 4.13e-06 | 713 | 134 | 13 | 29802200 | |
| Pubmed | RALGAPA1 ANK2 MYCBP2 ATAD5 LSG1 UBR4 ANKRD26 SMARCAD1 TTK GRSF1 LARP7 TFRC ESYT2 SENP1 DDX18 CRYBG3 NUDC VPS13B TOP2B | 4.52e-06 | 1487 | 134 | 19 | 33957083 | |
| Pubmed | AKAP6 ARHGAP15 BMP2K OBSCN BCOR ANKHD1 WLS GRSF1 MEN1 SLC44A1 CLCNKA MASTL CEP295 UTRN CNOT1 VPS13B | 4.63e-06 | 1084 | 134 | 16 | 11544199 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 4.74e-06 | 322 | 134 | 9 | 39098523 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TUT4 PITRM1 BMP2K MYCBP2 LSG1 UBR4 DHX57 TTK GRSF1 ESYT2 SENP1 MAGED2 DDX18 ARHGAP12 CRYBG3 DDX41 NUDC TOP2A VPS13B | 4.93e-06 | 1496 | 134 | 19 | 32877691 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | WRN CKAP5 ANKRD26 DHX57 ANKHD1 GRSF1 MEF2C LARP7 ESYT2 DDX18 XRN1 NAV2 CNOT1 | 5.49e-06 | 732 | 134 | 13 | 34732716 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | CALD1 TBC1D5 UBR4 CKAP5 PAIP1 TFRC ESYT2 MRTFB MAGED2 DDX18 NCAPD2 GMPPB NUDC UTRN CNOT1 PALLD HCFC1 TOP2A | 5.49e-06 | 1367 | 134 | 18 | 32687490 |
| Pubmed | MED20 RBPMS MYL6 NEDD4L ANK2 LSG1 ICAM1 WRN DHX57 ANKHD1 GRSF1 LARP7 MAGED2 DDX18 DDX41 CNOT1 HCFC1 RSBN1L | 5.71e-06 | 1371 | 134 | 18 | 36244648 | |
| Pubmed | 6.06e-06 | 332 | 134 | 9 | 25693804 | ||
| Pubmed | 6.51e-06 | 335 | 134 | 9 | 15741177 | ||
| Pubmed | 6.64e-06 | 253 | 134 | 8 | 29911972 | ||
| Pubmed | AKAP6 RALGAPA1 RELCH PITRM1 BCOR ANKHD1 PLPPR4 NRXN2 NCAPD2 NAV2 CNOT1 | 6.94e-06 | 529 | 134 | 11 | 14621295 | |
| Pubmed | 7.33e-06 | 340 | 134 | 9 | 24332808 | ||
| Pubmed | RELCH TUT4 MYL6 NEDD4L ANK2 MYCBP2 UBR4 CKAP5 ESYT2 PLPPR4 GPR158 XRN1 LRRC7 CRYBG3 NUDC CNOT1 | 8.59e-06 | 1139 | 134 | 16 | 36417873 | |
| Pubmed | RBL1 LSG1 TBC1D5 DHX57 SMARCAD1 ANKHD1 WLS XRN1 CRYBG3 PALLD HCFC1 RSBN1L | 8.71e-06 | 650 | 134 | 12 | 38777146 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 TCF20 NEDD4L CALD1 MYCBP2 POLR2E CKAP5 TFRC DDX18 DDX41 NUDC UTRN CNOT1 TOP2A TOP2B | 1.02e-05 | 1024 | 134 | 15 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 MYL6 TCF20 ATAD5 POLR2E WRN CKAP5 BCOR MEN1 ESYT2 USP42 DDX18 ZNHIT1 DDX41 HCFC1 TOP2A TOP2B | 1.05e-05 | 1294 | 134 | 17 | 30804502 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.11e-05 | 358 | 134 | 9 | 32460013 | |
| Pubmed | MYL6 MYCBP2 LSG1 ICAM1 UBR4 CKAP5 TTK ESYT2 SLC44A1 MAGED2 DDX18 NCAPD2 XRN1 DDX41 CNOT1 HCFC1 | 1.17e-05 | 1168 | 134 | 16 | 19946888 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.19e-05 | 457 | 134 | 10 | 32344865 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.26e-05 | 364 | 134 | 9 | 24778252 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 24048577 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 1.47e-05 | 2 | 134 | 2 | 27335120 | |
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 1.47e-05 | 2 | 134 | 2 | 19222228 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 8812470 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 2555055 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 1331984 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31106979 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16091284 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25919862 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 38637838 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 32535049 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 1380833 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 1.47e-05 | 2 | 134 | 2 | 38069401 | |
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 1.47e-05 | 2 | 134 | 2 | 23399433 | |
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 1.47e-05 | 2 | 134 | 2 | 15044480 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17526531 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 1.47e-05 | 2 | 134 | 2 | 20805576 | |
| Pubmed | DNA topoisomerase II distribution in mouse preimplantation embryos. | 1.47e-05 | 2 | 134 | 2 | 11835579 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 2556712 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 1.47e-05 | 2 | 134 | 2 | 15044642 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 10473615 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9224616 | ||
| Pubmed | DNA damage response during chromatin remodeling in elongating spermatids of mice. | 1.47e-05 | 2 | 134 | 2 | 18032420 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22111588 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 1.47e-05 | 2 | 134 | 2 | 17578914 | |
| Interaction | SNRNP40 interactions | HIVEP1 MYL6 TCF20 ATAD5 RBL1 WRN SMARCAD1 BCOR LARP7 MEN1 SENP1 USP42 DDX18 MASTL ELF1 DDX41 TOP2A RSBN1L TOP2B | 3.53e-08 | 637 | 132 | 19 | int:SNRNP40 |
| Interaction | NUP43 interactions | HIVEP1 TCF20 WRN CCDC168 SMARCAD1 BCOR LARP7 TDRD7 SENP1 MRTFB DDX18 ELF1 NUDC CNOT1 HCFC1 TOP2A TOP2B ZNF292 | 1.41e-07 | 625 | 132 | 18 | int:NUP43 |
| Interaction | HDAC1 interactions | HIVEP1 TCF20 MYCBP2 RBL1 UBR4 WRN CKAP5 SMARCAD1 BCOR ANKHD1 CREBBP ZEB2 LARP7 MEN1 NEK1 SENP1 MRTFB NCAPD2 XRN1 CRYBG3 UTRN HCFC1 TOP2A TOP2B | 2.06e-07 | 1108 | 132 | 24 | int:HDAC1 |
| Interaction | KCNA3 interactions | RALGAPA1 NEDD4L ANK2 CALD1 LSG1 CKAP5 ANKRD26 TTK TFRC ESYT2 LATS1 MAGED2 ARHGAP12 NCAPD2 XRN1 LRRC7 CRYBG3 NUDC CNOT1 PALLD HCFC1 | 2.32e-07 | 871 | 132 | 21 | int:KCNA3 |
| Interaction | NAA40 interactions | ZC3H14 MYL6 ANK2 CALD1 ATAD5 LSG1 TBC1D5 CKAP5 ANKRD26 BCOR ANKHD1 NEK1 MRTFB XRN1 MASTL NUDC UTRN PALLD HCFC1 TOP2A RSBN1L TOP2B | 3.77e-07 | 978 | 132 | 22 | int:NAA40 |
| Interaction | H3-3A interactions | HIVEP1 TCF20 ATAD5 WRN CKAP5 SMARCAD1 BCOR CREBBP ZEB2 MEN1 SBNO1 MASTL ELF1 DDX41 NUDC HCFC1 TOP2A TOP2B ZNF292 | 4.33e-07 | 749 | 132 | 19 | int:H3-3A |
| Interaction | WWTR1 interactions | TCF20 CALD1 MYCBP2 BCOR ANKHD1 CREBBP NEK1 LATS1 NCAPD2 XRN1 NUDC CNOT1 HCFC1 TOP2A | 7.29e-07 | 422 | 132 | 14 | int:WWTR1 |
| Interaction | RNF43 interactions | TCF20 OBSCN CKAP5 ANKRD26 TTK PAIP1 USP42 XRN1 LRRC7 N4BP1 CRYBG3 UTRN CNOT1 VPS13B | 8.39e-07 | 427 | 132 | 14 | int:RNF43 |
| Interaction | YWHAH interactions | RALGAPA1 ZC3H14 HIVEP1 TCF20 NEDD4L MYCBP2 LSG1 TBC1D5 CKAP5 ANKRD26 TTK DNAH7 CREBBP NEK1 ESYT2 LATS1 XRN1 NAV2 ARHGEF4 CRYBG3 UTRN PALLD | 2.73e-06 | 1102 | 132 | 22 | int:YWHAH |
| Interaction | PHF21A interactions | HIVEP1 MYCBP2 UBR4 CKAP5 BCOR ANKHD1 ZEB2 NEK1 MRTFB XRN1 CRYBG3 UTRN | 2.74e-06 | 343 | 132 | 12 | int:PHF21A |
| Interaction | HDAC2 interactions | ZC3H14 TCF20 BMP2K MYCBP2 RBL1 WRN DHX57 SMARCAD1 CREBBP ZEB2 LARP7 MEN1 TFRC SENP1 MAGED2 NCAPD2 HCFC1 TOP2A TOP2B | 3.65e-06 | 865 | 132 | 19 | int:HDAC2 |
| Interaction | POLR1G interactions | TCF20 ATAD5 UBR4 POLR2E SMARCAD1 ZEB2 LARP7 MEN1 SBNO1 DDX18 TOP2A RSBN1L TOP2B ZNF292 | 4.08e-06 | 489 | 132 | 14 | int:POLR1G |
| Interaction | CDH1 interactions | COL17A1 CALD1 POLR2E CKAP5 TTK TMEM87A CREBBP ESYT2 MRTFB XRN1 NAV2 LRRC7 N4BP1 NUDC UTRN HCFC1 TOP2A | 1.13e-05 | 768 | 132 | 17 | int:CDH1 |
| Interaction | H2BC21 interactions | TCF20 ATAD5 POLR2E OBSCN NEB BCOR CREBBP LARP7 MEN1 DNAAF2 MRTFB USP42 HCFC1 TOP2A TOP2B ZNF292 | 1.31e-05 | 696 | 132 | 16 | int:H2BC21 |
| Interaction | IFI16 interactions | ZC3H14 ICAM1 OBSCN CKAP5 DHX57 GRSF1 LARP7 MEN1 MAGED2 DDX18 XRN1 DDX41 CNOT1 TOP2A RSBN1L TOP2B | 1.79e-05 | 714 | 132 | 16 | int:IFI16 |
| Interaction | CEBPA interactions | MED20 ZC3H14 HIVEP1 MYL6 TCF20 ARHGAP15 MYCBP2 RBL1 CKAP5 BCOR CREBBP ZEB2 CCDC7 DDX18 ELF1 DDX41 NUDC CNOT1 HCFC1 TOP2A TOP2B ZNF292 | 1.88e-05 | 1245 | 132 | 22 | int:CEBPA |
| Interaction | CSNK2A2 interactions | MED20 TUT4 TCF20 RBL1 POLR2E EFCAB14 BCOR CREBBP ZEB2 LARP7 MEN1 DNAAF2 LATS1 DDX41 CNOT1 TOP2A | 1.92e-05 | 718 | 132 | 16 | int:CSNK2A2 |
| Interaction | NIN interactions | TBC1D5 CKAP5 ANKRD26 TTK MEN1 ESYT2 SENP1 LATS1 XRN1 CEP295 PALLD | 2.49e-05 | 359 | 132 | 11 | int:NIN |
| Interaction | MIB1 interactions | 2.51e-05 | 295 | 132 | 10 | int:MIB1 | |
| Interaction | SP1 interactions | NEDD4L PITRM1 RBL1 ICAM1 NEB BCOR CREBBP MEF2C ELF1 NUDC HCFC1 | 2.90e-05 | 365 | 132 | 11 | int:SP1 |
| Interaction | EGLN3 interactions | TUT4 BMP2K MYCBP2 LSG1 UBR4 POLR2E KIAA0586 CKAP5 BCOR ANKHD1 TTK CREBBP DNAAF2 SENP1 MAGED2 XRN1 MASTL CEP295 GMPPB UTRN CNOT1 HCFC1 | 3.47e-05 | 1296 | 132 | 22 | int:EGLN3 |
| Interaction | KDM1A interactions | KIAA0408 HIVEP1 TCF20 ARHGAP15 MYCBP2 UBR4 CKAP5 UBA3 SMARCAD1 BCOR ANKHD1 ZEB2 NEK1 MRTFB XRN1 CRYBG3 UTRN CNOT1 | 4.27e-05 | 941 | 132 | 18 | int:KDM1A |
| Interaction | KBTBD4 interactions | 4.50e-05 | 316 | 132 | 10 | int:KBTBD4 | |
| Interaction | MKRN2 interactions | ZC3H14 NEDD4L ANKRD26 DHX57 BCOR PAIP1 TDRD7 SLIT1 CNOT1 TOP2A TOP2B | 4.71e-05 | 385 | 132 | 11 | int:MKRN2 |
| Interaction | SOX2 interactions | HIVEP1 TCF20 ATAD5 UBR4 WRN CKAP5 ANKRD26 DHX57 BCOR ANKHD1 GRSF1 ZEB2 MEF2C LARP7 ESYT2 MAGED2 DDX18 NCAPD2 XRN1 NAV2 DDX41 CNOT1 ZNF292 | 4.76e-05 | 1422 | 132 | 23 | int:SOX2 |
| Interaction | NINL interactions | MYL6 BMP2K CKAP5 ANKRD26 TTK LATS1 XRN1 CEP295 CNOT1 PALLD TOP2A L3MBTL4 | 4.89e-05 | 458 | 132 | 12 | int:NINL |
| Interaction | CSNK2A1 interactions | CALD1 ATAD5 RBL1 ICAM1 POLR2E SMARCAD1 EFCAB14 BCOR CREBBP ZEB2 MEF2C LARP7 MEN1 ASXL3 NCAPD2 DDX41 HCFC1 TOP2A | 5.24e-05 | 956 | 132 | 18 | int:CSNK2A1 |
| Interaction | GRWD1 interactions | UBR4 CKAP5 LARP7 MEN1 ESYT2 MAGED2 DDX18 CNOT1 HCFC1 TOP2A TOP2B | 5.29e-05 | 390 | 132 | 11 | int:GRWD1 |
| Interaction | FBXO22 interactions | OBSCN DHX57 NEB TMEM87A MAP3K4 NCAPD2 NAV2 NUDC CNOT1 HCFC1 HYDIN RSBN1L ZNF292 | 5.59e-05 | 540 | 132 | 13 | int:FBXO22 |
| Interaction | LRRC31 interactions | 6.27e-05 | 205 | 132 | 8 | int:LRRC31 | |
| Interaction | DYRK1A interactions | RALGAPA1 CALD1 MYCBP2 RBL1 CKAP5 ANKHD1 TTK CREBBP XRN1 UTRN CNOT1 PALLD RSBN1L | 6.98e-05 | 552 | 132 | 13 | int:DYRK1A |
| Interaction | CEP120 interactions | 7.03e-05 | 106 | 132 | 6 | int:CEP120 | |
| Interaction | HECTD1 interactions | ZC3H14 MYCBP2 ATAD5 POLR2E WRN CKAP5 DHX57 GRSF1 LARP7 MAGED2 DDX18 NCAPD2 XRN1 DDX41 UTRN CNOT1 TOP2A TOP2B | 7.58e-05 | 984 | 132 | 18 | int:HECTD1 |
| Interaction | TERF2 interactions | RALGAPA1 CALD1 PITRM1 BMP2K WRN CKAP5 LARP7 UTRN TOP2A RSBN1L | 8.28e-05 | 340 | 132 | 10 | int:TERF2 |
| Interaction | FKBP5 interactions | TUT4 POLR2E LARP7 LATS1 MAGED2 DDX18 NUDC PALLD HCFC1 TOP2A TOP2B | 9.01e-05 | 414 | 132 | 11 | int:FKBP5 |
| Interaction | RCOR1 interactions | HIVEP1 MYCBP2 UBR4 CKAP5 BCOR ANKHD1 ZEB2 NEK1 MRTFB NCAPD2 XRN1 UTRN | 1.00e-04 | 494 | 132 | 12 | int:RCOR1 |
| Interaction | SIRT7 interactions | ZC3H14 TCF20 MYCBP2 UBR4 CKAP5 DHX57 ANKHD1 LARP7 DDX18 NCAPD2 XRN1 UTRN CNOT1 HCFC1 TOP2A | 1.10e-04 | 744 | 132 | 15 | int:SIRT7 |
| Interaction | HDAC4 interactions | TMEM94 LSG1 UBR4 DHX57 GRIK2 BCOR ZEB2 MEF2C LARP7 SENP1 NWD2 GPR158 SLIT1 NUDC TOP2B | 1.10e-04 | 744 | 132 | 15 | int:HDAC4 |
| Interaction | DCP1A interactions | 1.13e-04 | 166 | 132 | 7 | int:DCP1A | |
| Interaction | IGF2BP2 interactions | 1.24e-04 | 357 | 132 | 10 | int:IGF2BP2 | |
| Interaction | MEN1 interactions | ZC3H14 TCF20 LSG1 UBR4 POLR2E SMARCAD1 MEN1 TFRC SENP1 MRTFB SBNO1 DDX18 NCAPD2 DDX41 HCFC1 TOP2A RSBN1L TOP2B | 1.33e-04 | 1029 | 132 | 18 | int:MEN1 |
| Interaction | MTA2 interactions | TCF20 SMARCAD1 BCOR TTK ZEB2 LARP7 MEN1 LATS1 NCAPD2 TOP2A TOP2B | 1.39e-04 | 435 | 132 | 11 | int:MTA2 |
| Interaction | CSK interactions | ZC3H14 TUT4 HIVEP1 TBC1D5 ANKHD1 WLS TMEM87A CREBBP GRSF1 ERLEC1 CCDC7 MAGED2 HYDIN VPS13B ALPK2 ARL14 | 1.64e-04 | 861 | 132 | 16 | int:CSK |
| Interaction | CPAP interactions | 1.99e-04 | 182 | 132 | 7 | int:CPAP | |
| Interaction | SOX7 interactions | 2.04e-04 | 82 | 132 | 5 | int:SOX7 | |
| Interaction | ARPC3 interactions | 2.06e-04 | 183 | 132 | 7 | int:ARPC3 | |
| Interaction | CDC16 interactions | 2.21e-04 | 246 | 132 | 8 | int:CDC16 | |
| Interaction | YTHDF3 interactions | 2.21e-04 | 246 | 132 | 8 | int:YTHDF3 | |
| Interaction | MYB interactions | 2.45e-04 | 133 | 132 | 6 | int:MYB | |
| Interaction | SIRT6 interactions | MYCBP2 LSG1 BCOR CREBBP LARP7 MAP3K4 SENP1 MAGED2 DDX18 NCAPD2 PALLD TOP2A TOP2B | 2.50e-04 | 628 | 132 | 13 | int:SIRT6 |
| Interaction | SMG7 interactions | 2.57e-04 | 319 | 132 | 9 | int:SMG7 | |
| Interaction | XIRP2 interactions | 2.74e-04 | 48 | 132 | 4 | int:XIRP2 | |
| Interaction | TERF2IP interactions | ZC3H14 HIVEP1 TCF20 ATAD5 BCOR CREBBP LARP7 SBNO1 MASTL HCFC1 TOP2A ZNF292 | 2.80e-04 | 552 | 132 | 12 | int:TERF2IP |
| Interaction | PLPPR1 interactions | 2.89e-04 | 20 | 132 | 3 | int:PLPPR1 | |
| Interaction | KLF5 interactions | 3.03e-04 | 195 | 132 | 7 | int:KLF5 | |
| Interaction | H2BC3 interactions | TCF20 ATAD5 ICAM1 POLR2E CREBBP GRSF1 LARP7 MEN1 MAGED2 UTRN | 3.47e-04 | 406 | 132 | 10 | int:H2BC3 |
| Interaction | FBXW7 interactions | MED20 ZC3H14 MYL6 MYCBP2 UBR4 POLR2E DHX57 ANKHD1 ZEB2 FABP6 TFRC MAGED2 NCAPD2 MASTL DDX41 NUDC TOP2A RSBN1L TOP2B | 3.58e-04 | 1215 | 132 | 19 | int:FBXW7 |
| Interaction | XRCC6 interactions | KIAA0408 TCF20 ICAM1 WRN NCF4 SMARCAD1 CREBBP LARP7 MRTFB ASXL3 NCAPD2 NUDC HCFC1 TOP2A RSBN1L TOP2B | 3.79e-04 | 928 | 132 | 16 | int:XRCC6 |
| Interaction | CDC42 interactions | RALGAPA1 MYL6 TBC1D5 WRN ANKRD26 TMEM87A GRSF1 MAP3K4 TFRC ESYT2 SENP1 SBNO1 DDX18 NCAPD2 MASTL ARHGEF4 UTRN CNOT1 PALLD TOP2B | 3.83e-04 | 1323 | 132 | 20 | int:CDC42 |
| Interaction | CBX4 interactions | 4.10e-04 | 205 | 132 | 7 | int:CBX4 | |
| Interaction | BIRC3 interactions | HIVEP1 MYL6 PITRM1 LSG1 UBR4 KIAA0586 CKAP5 SMARCAD1 GRSF1 TFRC GBA3 MAGED2 DDX18 NCAPD2 DDX41 NUDC CNOT1 HCFC1 TOP2A TOP2B | 4.26e-04 | 1334 | 132 | 20 | int:BIRC3 |
| Cytoband | 2q22 | 8.46e-06 | 2 | 134 | 2 | 2q22 | |
| Cytoband | 10p12.1 | 1.13e-04 | 32 | 134 | 3 | 10p12.1 | |
| GeneFamily | Topoisomerases | 2.73e-04 | 6 | 78 | 2 | 1050 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 3.80e-04 | 7 | 78 | 2 | 625 | |
| GeneFamily | Ankyrin repeat domain containing | 6.21e-04 | 242 | 78 | 6 | 403 | |
| GeneFamily | Chloride voltage-gated channels | 8.09e-04 | 10 | 78 | 2 | 302 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.69e-03 | 18 | 78 | 2 | 91 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZC3H14 TUT4 RBPMS RAB31 HIVEP1 BMP2K MYCBP2 WRN CKAP5 TTK TMEM87A CREBBP PAIP1 ZEB2 MAP3K4 TDRD7 NEK1 ARHGAP12 N4BP1 CRYBG3 TOP2A VPS13B ZNF292 | 6.00e-11 | 856 | 133 | 23 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 TUT4 TMEM94 WRN CKAP5 CREBBP SBNO1 NCAPD2 UTRN HCFC1 | 2.96e-08 | 180 | 133 | 10 | M8239 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.02e-07 | 155 | 133 | 9 | M39246 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.62e-06 | 81 | 133 | 6 | M39253 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN | 8.66e-06 | 200 | 133 | 8 | M8037 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 8.66e-06 | 200 | 133 | 8 | M8559 | |
| Coexpression | GSE7852_TREG_VS_TCONV_UP | 8.66e-06 | 200 | 133 | 8 | M5751 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.75e-05 | 289 | 133 | 9 | M2196 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 TUT4 ARHGAP15 MYCBP2 UBR4 CREBBP ZEB2 ESYT2 LATS1 GVINP1 USP42 SBNO1 XRN1 ELF1 N4BP1 LY9 UTRN CNOT1 VPS13B TOP2B ZNF292 | 2.03e-05 | 1492 | 133 | 21 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TUT4 HIVEP1 MYCBP2 WRN CKAP5 CREBBP PAIP1 TDRD7 ARHGAP12 TOP2A ZNF292 | 2.69e-05 | 466 | 133 | 11 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TUT4 CALD1 MYCBP2 WRN SMARCAD1 ANKHD1 TTK PAIP1 LARP7 TDRD7 NEK1 PALLD TOP2B | 3.07e-05 | 656 | 133 | 13 | M18979 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TCF20 ANK2 ARHGAP15 BCOR TTK CREBBP ZEB2 ESYT2 MAGED2 ARHGAP12 XRN1 NAV2 MYO18B NUDC TOP2A VPS13B | 5.45e-05 | 1009 | 133 | 16 | M157 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN | 7.26e-05 | 199 | 133 | 7 | M3731 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN | 7.49e-05 | 200 | 133 | 7 | M5966 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 7.49e-05 | 200 | 133 | 7 | M8090 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 7.49e-05 | 200 | 133 | 7 | M8554 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP | 7.49e-05 | 200 | 133 | 7 | M3605 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 7.49e-05 | 200 | 133 | 7 | M9777 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 7.49e-05 | 200 | 133 | 7 | M7958 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 7.49e-05 | 200 | 133 | 7 | M6745 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 7.81e-05 | 86 | 133 | 5 | M39247 | |
| Coexpression | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN | 8.03e-05 | 45 | 133 | 4 | M8813 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 1.21e-04 | 290 | 133 | 8 | M17183 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ATAD5 RBL1 KIAA0586 CKAP5 TTK MEF2C LARP7 DNAAF2 NCAPD2 PALLD TOP2A | 1.82e-04 | 578 | 133 | 11 | M2368 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.89e-04 | 163 | 133 | 6 | M8235 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RALGAPA1 RELCH TCF20 NEDD4L ATAD5 TBC1D5 KIAA0586 CKAP5 ANKRD26 DGKB DHX57 NCKAP5 ANKHD1 ERLEC1 NEK1 MRTFB LATS1 CEP295 TOP2B ZNF292 | 2.11e-07 | 831 | 132 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TUT4 ATAD5 TBC1D5 KIAA0586 CKAP5 ANKRD26 ANKHD1 NEK1 LATS1 CEP295 TOP2B ZNF292 | 5.74e-07 | 311 | 132 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | RELCH MYCBP2 WRN UBA3 CREBBP PAIP1 NEK1 LATS1 SBNO1 ASXL3 TOP2B | 7.03e-06 | 330 | 132 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | RALGAPA1 RELCH MYCBP2 WRN UBA3 PAIP1 TFRC LATS1 VPS13B TOP2B ZNF292 | 1.99e-05 | 369 | 132 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TUT4 NEDD4L ANK2 ATAD5 RBL1 KIAA0586 CKAP5 ANKRD26 TLR7 SMARCAD1 EFCAB14 TTK GRSF1 LARP7 MEN1 USP42 SBNO1 MASTL CEP295 TOP2A ZNF292 | 3.17e-05 | 1257 | 132 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | AKAP6 RBPMS ATAD5 TTK TFRC NCAPD2 MASTL NAV2 NUDC UTRN TOP2A | 3.98e-05 | 398 | 132 | 11 | GSM538338_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | CALD1 KIAA0586 ANKHD1 CREBBP ZEB2 MEF2C LARP7 SENP1 SBNO1 ASXL3 NAV2 CEP295 N4BP1 TAF4B UTRN TOP2A | 4.14e-05 | 806 | 132 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TUT4 NEDD4L ATAD5 TBC1D5 KIAA0586 CKAP5 ANKRD26 DGKB NCKAP5 GRIK2 ANKHD1 NEK1 LATS1 NRXN2 NAV2 CEP295 TOP2B ZNF292 | 4.15e-05 | 989 | 132 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AKAP6 RELCH TCF20 ANK2 MYCBP2 WRN DGKB UBA3 CREBBP PAIP1 NEK1 LATS1 SBNO1 ASXL3 CNTN3 TOP2B | 4.94e-05 | 818 | 132 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RBL1 TBC1D5 KIAA0586 NCKAP5 EFCAB14 PAIP1 NEK1 NRXN2 USP42 CEP295 N4BP1 TOP2A ZNF292 | 8.81e-05 | 595 | 132 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TUT4 NEDD4L ANK2 ATAD5 RBL1 KIAA0586 CKAP5 ANKRD26 GRIK2 TLR7 SMARCAD1 EFCAB14 TTK GRSF1 LARP7 MEN1 USP42 SBNO1 MASTL CEP295 TOP2A ZNF292 | 9.29e-05 | 1459 | 132 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | RALGAPA1 RELCH TUT4 MYCBP2 UBA3 TFRC PLPPR4 SBNO1 TOP2B ZNF292 | 1.21e-04 | 375 | 132 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | RALGAPA1 RELCH LARP6 MYCBP2 ZEB2 TFRC NEK1 SBNO1 ASXL3 VPS13B | 1.50e-04 | 385 | 132 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HIVEP1 MYCBP2 ATAD5 TBC1D5 KIAA0586 EFCAB14 NEK1 USP42 N4BP1 UTRN TOP2A ZNF292 | 2.12e-04 | 564 | 132 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NEDD4L ATAD5 CKAP5 ANKRD26 DGKB NCKAP5 NEB GRSF1 DNAAF2 LATS1 NRXN2 ELF1 TOP2B | 2.24e-04 | 654 | 132 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.32e-04 | 261 | 132 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 2.88e-04 | 21 | 132 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.07e-04 | 146 | 132 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | RALGAPA1 RELCH TUT4 CALD1 MYCBP2 SGCB UBA3 ZEB2 MEF2C TFRC NEK1 ESYT2 CNTN3 TOP2B | 3.26e-04 | 772 | 132 | 14 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RALGAPA1 TUT4 TCF20 RBL1 KIAA0586 ANKRD26 DHX57 ANKHD1 TTK ERLEC1 MRTFB LATS1 N4BP1 TOP2B | 3.61e-04 | 780 | 132 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.80e-04 | 152 | 132 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.35e-04 | 361 | 132 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ATAD5 CKAP5 ANKRD26 SMARCAD1 TTK GRSF1 ZEB2 LARP7 MAP3K4 DNAAF2 CNOT1 | 4.98e-04 | 532 | 132 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RALGAPA1 RELCH COL17A1 CALD1 MYCBP2 WRN UBA3 PAIP1 TFRC LATS1 CNTN3 VPS13B TOP2B ZNF292 | 5.00e-04 | 806 | 132 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIAA0408 TUT4 CALD1 KIAA0586 ANKRD26 SMARCAD1 CREBBP ZEB2 SENP1 ASXL3 CEP295 N4BP1 UTRN TOP2A | 5.58e-04 | 815 | 132 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.61e-04 | 298 | 132 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | AKAP6 NEDD4L ANK2 CALD1 OBSCN NCKAP5 NEB LRRC7 MYO18B PALLD ALPK2 L3MBTL4 | 5.37e-13 | 188 | 134 | 12 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | AKAP6 NEDD4L ANK2 CALD1 OBSCN NCKAP5 LRRC7 MYO18B PALLD ALPK2 L3MBTL4 | 1.58e-11 | 191 | 134 | 11 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | AKAP6 NEDD4L ANK2 CALD1 OBSCN NCKAP5 GRIK2 MYO18B PALLD ALPK2 L3MBTL4 | 1.87e-11 | 194 | 134 | 11 | 89812fb164065041357bb37a3c2d87028ec3de4e |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | AKAP6 NEDD4L ANK2 CALD1 OBSCN NCKAP5 GRIK2 MYO18B PALLD ALPK2 L3MBTL4 | 1.87e-11 | 194 | 134 | 11 | c3535f7cc0076653c72db582047cff053c322397 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-08 | 184 | 134 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-08 | 185 | 134 | 8 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.11e-07 | 189 | 134 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.15e-07 | 190 | 134 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.15e-07 | 190 | 134 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.25e-07 | 192 | 134 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.58e-07 | 198 | 134 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-07 | 145 | 134 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.16e-07 | 162 | 134 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.21e-07 | 172 | 134 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 182 | 134 | 7 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 182 | 134 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 183 | 134 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 183 | 134 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 134 | 7 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.45e-06 | 184 | 134 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 134 | 7 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.50e-06 | 185 | 134 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-06 | 188 | 134 | 7 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 188 | 134 | 7 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.73e-06 | 189 | 134 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-06 | 189 | 134 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.73e-06 | 189 | 134 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-06 | 190 | 134 | 7 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-06 | 190 | 134 | 7 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 190 | 134 | 7 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 190 | 134 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.79e-06 | 190 | 134 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.79e-06 | 190 | 134 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 191 | 134 | 7 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.90e-06 | 122 | 134 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 192 | 134 | 7 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 193 | 134 | 7 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.99e-06 | 193 | 134 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.99e-06 | 193 | 134 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.99e-06 | 193 | 134 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.99e-06 | 193 | 134 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 194 | 134 | 7 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 194 | 134 | 7 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.13e-06 | 195 | 134 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.13e-06 | 195 | 134 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.13e-06 | 195 | 134 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 196 | 134 | 7 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.28e-06 | 197 | 134 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 197 | 134 | 7 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.35e-06 | 198 | 134 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-06 | 198 | 134 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 199 | 134 | 7 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 199 | 134 | 7 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.43e-06 | 199 | 134 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.43e-06 | 199 | 134 | 7 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.43e-06 | 199 | 134 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.43e-06 | 199 | 134 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-06 | 160 | 134 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-06 | 160 | 134 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.08e-05 | 165 | 134 | 6 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 168 | 134 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-05 | 170 | 134 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 172 | 134 | 6 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-05 | 175 | 134 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-05 | 176 | 134 | 6 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 176 | 134 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.65e-05 | 105 | 134 | 5 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 179 | 134 | 6 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-05 | 179 | 134 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 180 | 134 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.77e-05 | 180 | 134 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 181 | 134 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.89e-05 | 182 | 134 | 6 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 182 | 134 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.95e-05 | 183 | 134 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 183 | 134 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 184 | 134 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | MED20 RBPMS BMP2K ICAM1 GRIK2 EFCAB14 SH3D21 SLC44A1 LATS1 HCFC1 | 2.76e-07 | 199 | 133 | 10 | 4562_DN |
| Disease | Bartter syndrome | 1.73e-06 | 6 | 132 | 3 | cv:C0004775 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.87e-05 | 12 | 132 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | Bartter disease type 4B | 1.99e-05 | 2 | 132 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 1.99e-05 | 2 | 132 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.99e-05 | 2 | 132 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 1.99e-05 | 2 | 132 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.99e-05 | 2 | 132 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 1.99e-05 | 2 | 132 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 1.99e-05 | 2 | 132 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | B cell deficiency (implicated_via_orthology) | 1.99e-05 | 2 | 132 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.23e-05 | 75 | 132 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Intellectual Disability | AKAP6 RALGAPA1 ZC3H14 TCF20 PITRM1 TMEM94 MEF2C LARP7 NRXN2 ZNF292 | 3.47e-05 | 447 | 132 | 10 | C3714756 |
| Disease | Malignant neoplasm of breast | AKAP6 ANK2 UBR4 OBSCN GRIK2 ZEB2 TFRC MAGED2 SBNO1 DDX18 LRRC7 ARHGEF4 TOP2A VPS13B | 3.34e-04 | 1074 | 132 | 14 | C0006142 |
| Disease | language measurement | 3.49e-04 | 134 | 132 | 5 | EFO_0007797 | |
| Disease | Large cell carcinoma of lung | 3.95e-04 | 32 | 132 | 3 | C0345958 | |
| Disease | PR interval | 4.02e-04 | 495 | 132 | 9 | EFO_0004462 | |
| Disease | neutrophil percentage of leukocytes | RBPMS HIVEP1 ARHGAP15 ATAD5 LSG1 ERLEC1 SBNO1 ELF1 TOP2A ZNF292 | 4.33e-04 | 610 | 132 | 10 | EFO_0007990 |
| Disease | Neurodevelopmental Disorders | 8.21e-04 | 93 | 132 | 4 | C1535926 | |
| Disease | lymphocyte percentage of leukocytes | RBPMS HIVEP1 ARHGAP15 RBL1 ERLEC1 MEF2C SBNO1 ELF1 LY9 ZNF292 | 8.41e-04 | 665 | 132 | 10 | EFO_0007993 |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 8.73e-04 | 10 | 132 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | proteinuria (biomarker_via_orthology) | 8.73e-04 | 10 | 132 | 2 | DOID:576 (biomarker_via_orthology) | |
| Disease | economic and social preference | 9.61e-04 | 97 | 132 | 4 | EFO_0004827 | |
| Disease | left ventricular systolic function measurement | 1.01e-03 | 44 | 132 | 3 | EFO_0008206 | |
| Disease | venous thromboembolism | 1.12e-03 | 460 | 132 | 8 | EFO_0004286 | |
| Disease | Colorectal Carcinoma | 1.26e-03 | 702 | 132 | 10 | C0009402 | |
| Disease | ghrelin measurement | 1.39e-03 | 49 | 132 | 3 | EFO_0600001 | |
| Disease | non-high density lipoprotein cholesterol measurement | HIVEP1 TIMD4 GRIK2 ESYT2 SBNO1 DDX18 XRN1 ZNHIT1 HYDIN ARL14 | 1.42e-03 | 713 | 132 | 10 | EFO_0005689 |
| Disease | atrial fibrillation | 1.44e-03 | 371 | 132 | 7 | EFO_0000275 | |
| Disease | neutrophil-to-lymphocyte ratio | 1.49e-03 | 185 | 132 | 5 | EFO_0008447 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.50e-03 | 13 | 132 | 2 | C0036996 | |
| Disease | Diverticular Bleeding | 1.50e-03 | 13 | 132 | 2 | C4505353 | |
| Disease | Diverticular Diseases | 1.50e-03 | 13 | 132 | 2 | C4317009 | |
| Disease | Saldino-Noonan Syndrome | 1.74e-03 | 14 | 132 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.74e-03 | 14 | 132 | 2 | C0024507 | |
| Disease | glycerol-3-phosphate measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0010488 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.15e-03 | 57 | 132 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | blood osmolality measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0007967 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.39e-03 | 206 | 132 | 5 | C0152013 | |
| Disease | verbal-numerical reasoning measurement | 2.89e-03 | 131 | 132 | 4 | EFO_0008394 | |
| Disease | Adrenocortical carcinoma | 2.90e-03 | 18 | 132 | 2 | C0206686 | |
| Disease | Tourette syndrome, schizophrenia | 2.90e-03 | 18 | 132 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 2.90e-03 | 18 | 132 | 2 | DOID:1273 (is_marker_for) | |
| Disease | fish consumption measurement | 2.99e-03 | 64 | 132 | 3 | EFO_0010139 | |
| Disease | FEV/FEC ratio | AKAP6 CALD1 TIMD4 ARHGAP15 KIAA0586 DGKB MYRFL NEB ZEB2 SH3D21 ARHGAP12 NAV2 TOP2B | 3.49e-03 | 1228 | 132 | 13 | EFO_0004713 |
| Disease | diaphragmatic hernia | 3.94e-03 | 21 | 132 | 2 | EFO_0008561 | |
| Disease | carotid artery intima media thickness | 4.22e-03 | 450 | 132 | 7 | EFO_0007117 | |
| Disease | Bronchiectasis | 4.33e-03 | 22 | 132 | 2 | C0006267 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNKAASQTMPNTQDK | 16 | Q86UN6 | |
| LNTSTKNVPGKMKVA | 781 | Q96QE3 | |
| GVKKNMPQSPAAVNT | 306 | Q9UMD9 | |
| EKSNEIPTKNIEGQM | 171 | Q96DZ1 | |
| GKKISSNPNPVVQMS | 551 | A0FGR8 | |
| QLSNSGPNSTIKMKI | 636 | A0FGR8 | |
| KENVMLQSQKAGSPP | 481 | P32519 | |
| TTMQVGNSQTKVKGE | 426 | Q96M83 | |
| VENEPMSTSQKKENV | 51 | Q68DQ2 | |
| TNISPKFQETGSMKV | 991 | Q68DQ2 | |
| KQPSIGKSKVQTNSM | 2141 | Q86TB3 | |
| LGPQQGTQMKTKEFT | 216 | Q7Z2Y8 | |
| KGVENPAVQESNQKM | 621 | Q96GX5 | |
| AMLNASKQQVTGKPK | 626 | Q9NR80 | |
| KQMHPNGEAKESQSI | 531 | A2A2Z9 | |
| TGVNPQLASKQSMVN | 291 | Q92793 | |
| MGSLGSKNPQTKQAQ | 1 | Q8N4G2 | |
| VPNKAGGMKDVQTSK | 506 | Q9UPS8 | |
| QMNKKLQTGFTEPEV | 141 | Q9NSY1 | |
| PNEENNGKSMSLKNK | 516 | Q6W2J9 | |
| NKSSNHPEMIQVGQK | 251 | Q8IVL8 | |
| TMESNQKSSFQEIPK | 111 | O75071 | |
| AQTALAEQQPKSMKS | 396 | Q9C0F0 | |
| ITAMSNIDKTGKPIQ | 1306 | Q9ULI1 | |
| ANTKMAKNKLVGTPN | 101 | Q93062 | |
| NNGTIKVEKPTMQAS | 176 | Q13636 | |
| MKSLQVKSSPVVNDG | 236 | Q12849 | |
| AQSQVQMKKQKVSTP | 586 | O00255 | |
| TSVQKTVAPQGQDMA | 3366 | Q01484 | |
| TPSGSMQQANKVSLK | 31 | Q8N9V6 | |
| KVENKTVQEPQGSMS | 1166 | Q9P260 | |
| GKVMSVVQTKPVQTS | 681 | P51610 | |
| TKKQNADPQAVTMPA | 106 | Q9UNF1 | |
| NVGKSSTINTIMGNK | 396 | Q9H089 | |
| GQNSISVMPAQKITK | 296 | Q96PY6 | |
| GKSQQPESKMQSEFI | 741 | Q9NVR5 | |
| ASMKPGNVQQSVNRK | 161 | O95835 | |
| GSSKGPQQQKASMTK | 1011 | Q96NW7 | |
| QKSGIMKQQRVNPTT | 971 | Q5T848 | |
| EKPQVFVSNKINAGM | 161 | Q9Y5P6 | |
| IQAEKNNKGPMEAAT | 41 | O95786 | |
| KTNQNTGMTLPAQKC | 666 | O95786 | |
| LPMLQTVAKNKDQGT | 71 | P60660 | |
| MIDSSKKQQQGFPEI | 1 | Q9ULH7 | |
| SLMKGNSDKPVNDNQ | 986 | Q9P2S2 | |
| SETTANNMRKKGKPN | 346 | Q96LU7 | |
| KVKSVSPQGNSVDRM | 156 | Q15080 | |
| NPTKKSTTGLVRQMQ | 511 | Q6ZU52 | |
| ATPQKNGRVQEKVME | 201 | Q9BRS8 | |
| VPQNTGMKNEKTANR | 421 | Q4G0J3 | |
| EATQTNAVPAKVFKM | 276 | Q8NA19 | |
| LVSPGNLNKNMQAKS | 226 | Q06413 | |
| PQIHTVTGTKNFMKN | 1231 | P00451 | |
| SKQKPMNVGLSETQN | 56 | Q9NVP1 | |
| PKLEAMQTKQVSNIG | 596 | Q9UJV9 | |
| KSKSVQLNGQPLVMV | 536 | Q8WWQ2 | |
| QGKEDISMNSVPIQQ | 111 | Q96PD4 | |
| QDKIPQQNSESAMAK | 101 | Q9H074 | |
| VKQVAGLPNNSTKIM | 81 | Q8IWW6 | |
| MVSAKITQAKLQVPG | 5546 | Q5VST9 | |
| GAMPQAQKKTTSVSL | 381 | Q8WX93 | |
| AEQVVSMAFSQKNPK | 716 | Q14008 | |
| INSMISVQPKKGSLT | 3096 | Q4G0P3 | |
| NQVSVKVTPKNTEMK | 11 | A1L168 | |
| EVVKSQIASMSQKQG | 266 | Q9H227 | |
| QKTSTGAVRMQPKSA | 1236 | Q6P158 | |
| NIQTMGGKTFKATVQ | 71 | P51161 | |
| SVLQNGVKMTNEAPK | 3531 | Q8WXX0 | |
| SGSQQPNKVIDKNKM | 401 | Q9Y6T7 | |
| EPQVTMKSVKVSENF | 156 | Q9HBG7 | |
| QKNTKLEAIPNSGMD | 71 | Q8WWI5 | |
| QAQKGTPMKPNTQAT | 516 | P05362 | |
| DMTTQKVQQQKAFPG | 6301 | Q8NDH2 | |
| QKKPNIRNTSSMAGE | 21 | Q7Z3D6 | |
| LNMTESQKGKPANIT | 411 | Q13002 | |
| KPTVENDLKTQKMGQ | 1761 | Q9C0D2 | |
| NAMTSAPSKDQVQLK | 141 | A3KN83 | |
| EMNPNNKVTKTQNLV | 1206 | Q6ZTR5 | |
| SKNPMKKLVQVQVGS | 411 | Q9P232 | |
| VSQMPVAEGKSVQQT | 6 | Q9H944 | |
| VKLKNNAQTMPGEVN | 1486 | Q9Y6R4 | |
| IPEKTTALNNMDGKN | 771 | Q6PCB5 | |
| GSQSPEMGQNVKKLV | 276 | Q92750 | |
| TLTIQKCGQKTMPVN | 551 | Q92750 | |
| TQAVAKLGMSQIPQK | 636 | P46939 | |
| VQQGMTPSAKQSLVD | 106 | P19388 | |
| LEVQVMQGTQKSQTP | 616 | A4FU49 | |
| SQTKENMTLQPKSFG | 396 | Q02880 | |
| SNKLTKQVTMLTGNG | 466 | Q9H4L7 | |
| QGSPEQKKEETVNIM | 126 | O14513 | |
| PLSMNTNQESKVKSP | 736 | P28749 | |
| QQEKPGSFSQKVMVG | 146 | A0A1B0GUY1 | |
| TKQVPIATAENMKNS | 1331 | Q8IVL1 | |
| SVNATPQQMPQTEKA | 781 | Q5JRX3 | |
| KQQALSNMKTGHKPE | 121 | Q53QZ3 | |
| LFSKKSQEIPQQMNG | 586 | Q9P0U3 | |
| VPVSQKKMSLQQDQA | 2311 | O75592 | |
| GSNISKKSIMVQSPE | 1121 | Q14191 | |
| MSDNLNQTVEKPNVK | 211 | Q8NHU6 | |
| QQSSNGPVKKSMREK | 11 | Q16585 | |
| IEKTMQNVKHPVTGQ | 506 | P02786 | |
| QKSMGLPTSDEQKKQ | 296 | Q9Y266 | |
| KNNPKVTGMTQPNVL | 1306 | Q13023 | |
| MSLKNGQISSEEPKQ | 226 | Q05682 | |
| PTKEKVSTQDQPMAN | 2026 | Q8IWZ3 | |
| TGNMVTGQTVCKNKP | 586 | Q15021 | |
| TTIGEPENKSKQNEM | 186 | P51800 | |
| TTIGEPENKSKQNEM | 186 | P51801 | |
| TSGLNQPTFQQSKMK | 811 | A5YKK6 | |
| AMSKQQGVLQSSPKN | 581 | Q7Z2D5 | |
| QMKSPAITATLEGKN | 396 | Q8TBC4 | |
| ESCSQPVMNGKSKLN | 586 | Q9H9J4 | |
| KLQPVTEVKTQMQHG | 1486 | Q6GYQ0 | |
| MATGKNLQSIPKKTQ | 1151 | Q12767 | |
| TPGQENMSSKANQEK | 2296 | O60281 | |
| SQKMSNKQPNSGIEN | 1306 | Q8IZH2 | |
| QKMSKSLGNVVDPRT | 346 | Q96GW9 | |
| SMKNFEQAKIPQGTQ | 296 | Q9UGU0 | |
| SNKIQMIQKTSFPEN | 756 | Q9NYK1 | |
| EKTGEPQTQMEKTSQ | 346 | Q8IUG5 | |
| PQTQMEKTSQVQGEL | 351 | Q8IUG5 | |
| QTKENMTLQPKSFGS | 376 | P11388 | |
| GIANQMQPDTTSVVK | 666 | P33981 | |
| PQMSSPVEKNQTFKS | 2281 | Q7Z7G8 | |
| MVEKKTSVRSQDPGQ | 1 | O43257 | |
| ESMPVQLNKGLSSKN | 521 | Q92609 | |
| NISGKQSSLPAMSKV | 406 | Q5T9L3 | |
| NKLENGKPLSMSEQT | 371 | O60315 | |
| NELQDFTKTQMKPGV | 1321 | O75093 | |
| SEMSIPQGQGAQIKK | 311 | Q5SRN2 | |
| SNKKPVKSNNMATNG | 731 | Q5TAX3 | |
| TLGMTTNEKGQVVTK | 4806 | Q5T4S7 | |
| FEGMKPVNQTAASNK | 541 | Q6PJT7 | |
| MPASQSKACETQPKQ | 2571 | P15822 | |
| AVPEQNKTTKTGQMD | 286 | Q96H15 | |
| DLGQKEKETNSMVQP | 426 | Q9BVV6 | |
| KMRSTKQEPNGNSKV | 496 | Q8NBN3 | |
| TPKKTQAHTQQNMVE | 426 | O75113 | |
| VDSPVMVQAKQNTKQ | 1241 | P20929 | |
| KPNGSEIMVTNENKR | 791 | Q96PU5 |